Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bromure de glycopyrronium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium adverse reaction |
Causative agent (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to glycopyrronium |
Causative agent (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide [antispasmodic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 200micrograms/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide 600micrograms/3mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 0.2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glycopyrronium bromide in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral glycopyrrolate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 100%w/w powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine+glycopyrronium 2.5mg/500micrograms/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine+glycopyrronium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 0.2mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 0.2mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 0.2mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 0.2mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 100%w/w powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide |
Is a |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide [antispasmodic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium bromide 600micrograms/3mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrrolate 200micrograms/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to glycopyrronium |
Causative agent (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glycopyrronium bromide and neostigmine bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing formoterol and glycopyrronium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glycopyrronium bromide and indacaterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing formoterol and glycopyrronium bromide in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glycopyrronium bromide and indacaterol in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 2 mg oral tablet |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has precise active ingredient |
False |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 320 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 160 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium (as glycopyrronium bromide) 44 microgram/actuation powder for inhalation |
Has precise active ingredient |
True |
Glycopyrrolate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |